Herantis Pharma Oyj (HEL:HRTIS)
Finland · Delayed Price · Currency is EUR 2.190
0.00 (0.00%)
At close: Feb 25, 2026
Herantis Pharma Oyj Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
56.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.89B |
| Terveystalo Oyj | 1.28B |
| Pihlajalinna Oyj | 652.30M |
| Revenio Group Oyj | 109.90M |
| Optomed Oyj | 17.10M |
| Biohit Oyj | 15.70M |
| Nexstim | 11.63M |
| Modulight Oyj | 10.35M |
Herantis Pharma Oyj News
- 6 weeks ago - Herantis Pharma Oyj Phase 1b Biomarker Data Transcript - GuruFocus
- 6 weeks ago - Herantis Pharma Oyj (HRPMF) Discusses Phase 1b Biomarker Data for HER-096 in Parkinson's Disease and Implications for Clinical Development Transcript - Seeking Alpha
- 4 months ago - Herantis Pharma Oyj (HRPMF) Presents at Nordic Life Science Days 2025 - Slideshow - Seeking Alpha
- 5 months ago - Herantis Pharma Oyj (HRPMF) Announcement of Positive Topline Results from Phase 1b Trial of HER-096 Transcript - Seeking Alpha
- 5 months ago - Herantis Pharma Oyj - Special Call - Seeking Alpha